Strata Skin Sciences Return on Tangible Equity 2010-2024 | SSKN

Current and historical return on tangible equity values for Strata Skin Sciences (SSKN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Strata Skin Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.01B $-0.00B 327.27%
2024-06-30 $-0.01B $-0.00B 320.00%
2024-03-31 $-0.01B $-0.00B 293.33%
2023-12-31 $-0.01B $-0.00B 258.82%
2023-09-30 $-0.01B $-0.00B 140.00%
2023-06-30 $-0.01B $-0.01B 121.74%
2023-03-31 $-0.01B $-0.01B 120.00%
2022-12-31 $-0.01B $-0.00B 126.32%
2022-09-30 $-0.01B $-0.01B 350.00%
2022-06-30 $-0.01B $-0.01B -700.00%
2022-03-31 $-0.00B $-0.01B -80.00%
2021-12-31 $-0.00B $0.01B -35.29%
2021-09-30 $-0.00B $0.01B -21.05%
2021-06-30 $-0.00B $0.01B -19.51%
2021-03-31 $-0.01B $0.01B -48.78%
2020-12-31 $-0.00B $0.01B -36.36%
2020-09-30 $-0.01B $0.01B -44.44%
2020-06-30 $-0.01B $0.01B -42.55%
2020-03-31 $-0.00B $0.01B -33.33%
2019-12-31 $-0.00B $0.01B -33.33%
2019-09-30 $-0.00B $0.01B -24.49%
2019-06-30 $-0.00B $0.01B -23.08%
2019-03-31 $-0.00B $0.01B -22.22%
2018-12-31 $-0.00B $0.01B -38.10%
2018-09-30 $-0.01B $0.02B -114.29%
2018-06-30 $-0.02B $0.01B -525.00%
2018-03-31 $-0.02B $0.00B 1050.00%
2017-12-31 $-0.02B $-0.00B 466.67%
2017-09-30 $-0.02B $0.00B 300.00%
2017-06-30 $-0.01B $-0.01B 70.59%
2017-03-31 $-0.01B $-0.01B 66.67%
2016-12-31 $-0.00B $-0.01B 55.17%
2016-09-30 $-0.00B $-0.01B 53.33%
2016-06-30 $-0.01B $-0.01B 175.00%
2016-03-31 $-0.02B $-0.01B 366.67%
2015-12-31 $-0.03B $-0.01B 1600.00%
2015-09-30 $-0.03B $-0.01B -1015.38%
2015-06-30 $-0.02B $0.00B -248.65%
2015-03-31 $-0.01B $0.01B -133.33%
2014-12-31 $-0.02B $0.01B -150.00%
2014-09-30 $-0.01B $0.02B -155.56%
2014-06-30 $-0.02B $0.01B -245.16%
2014-03-31 $-0.03B $0.01B -263.41%
2013-12-31 $-0.03B $0.01B -179.31%
2013-09-30 $-0.03B $0.01B -168.75%
2013-06-30 $-0.03B $0.02B -138.89%
2013-03-31 $-0.02B $0.02B -124.32%
2012-12-31 $-0.02B $0.01B -117.33%
2012-09-30 $-0.02B $0.02B -92.31%
2012-06-30 $-0.02B $0.02B -95.65%
2012-03-31 $-0.02B $0.02B -91.67%
2011-12-31 $-0.02B $0.03B -84.85%
2011-09-30 $-0.02B $0.02B -83.17%
2011-06-30 $-0.02B $0.02B -67.23%
2011-03-31 $-0.02B $0.03B -65.57%
2010-12-31 $-0.02B $0.03B -63.49%
2010-09-30 $-0.02B $0.04B -67.74%
2010-06-30 $-0.02B $0.03B -75.00%
2010-03-31 $-0.02B $0.03B -85.11%
2009-12-31 $-0.02B $0.03B -102.70%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.033B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.709B 54.09
Hims & Hers Health (HIMS) United States $11.210B 183.25
Tempus AI (TEM) United States $10.954B 0.00
Inspire Medical Systems (INSP) United States $5.532B 107.78
IRhythm Technologies (IRTC) United States $3.734B 0.00
Privia Health (PRVA) United States $2.941B 245.10
Enovis (ENOV) United States $2.475B 16.49
Clover Health Investments (CLOV) United States $2.095B 0.00
Azenta (AZTA) United States $2.083B 96.98
Omnicell (OMCL) United States $1.845B 40.23
Schrodinger (SDGR) United States $1.580B 0.00
Phreesia (PHR) United States $1.577B 0.00
10x Genomics (TXG) United States $1.381B 0.00
Butterfly Network (BFLY) United States $0.859B 0.00
Fulgent Genetics (FLGT) United States $0.512B 0.00
Standard BioTools (LAB) United States $0.495B 0.00
Talkspace (TALK) United States $0.481B 285.00
TruBridge (TBRG) United States $0.423B 123.26
Nyxoah SA (NYXH) Belgium $0.353B 0.00
Pulmonx (LUNG) United States $0.352B 0.00
Health Catalyst (HCAT) United States $0.305B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.257B 0.00
American Well (AMWL) United States $0.174B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
MDxHealth SA (MDXH) Belgium $0.085B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
111 (YI) China $0.072B 0.00
CareCloud (CCLD) United States $0.054B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
Movano (MOVE) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00